UNICA IRIS Institutional Research Information System

LACHOWICZ, JOANNA IZABELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 153.365
NA - Nord America 7.709
AS - Asia 3.547
SA - Sud America 571
AF - Africa 102
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 165.312
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 150.437
US - Stati Uniti d'America 7.559
SG - Singapore 1.344
CN - Cina 1.156
NL - Olanda 1.085
SE - Svezia 548
BR - Brasile 438
UA - Ucraina 359
VN - Vietnam 307
FI - Finlandia 198
DE - Germania 194
GB - Regno Unito 190
FR - Francia 152
IN - India 106
HK - Hong Kong 102
CA - Canada 89
KR - Corea 78
SA - Arabia Saudita 70
BD - Bangladesh 53
AR - Argentina 43
IQ - Iraq 42
MX - Messico 42
TR - Turchia 42
JP - Giappone 39
PK - Pakistan 35
ES - Italia 33
RU - Federazione Russa 27
IR - Iran 25
ID - Indonesia 24
EC - Ecuador 22
AT - Austria 21
ZA - Sudafrica 21
PL - Polonia 20
EG - Egitto 18
MA - Marocco 18
CO - Colombia 17
IE - Irlanda 17
UZ - Uzbekistan 17
BE - Belgio 16
VE - Venezuela 15
AU - Australia 13
RO - Romania 13
AE - Emirati Arabi Uniti 11
CL - Cile 11
KE - Kenya 11
TN - Tunisia 11
MY - Malesia 10
GR - Grecia 9
IL - Israele 9
JO - Giordania 9
LT - Lituania 9
PH - Filippine 9
CH - Svizzera 8
TH - Thailandia 8
BO - Bolivia 7
PY - Paraguay 6
UY - Uruguay 6
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
NP - Nepal 5
PA - Panama 5
PE - Perù 5
PS - Palestinian Territory 5
TW - Taiwan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
LB - Libano 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
KW - Kuwait 3
QA - Qatar 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
MN - Mongolia 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
Totale 165.293
Salva come PNG Salva come JPEG
Città #
Cagliari 147.437
Uta 2.475
Amsterdam 1.064
Ashburn 1.019
Fairfield 709
Singapore 663
Woodbridge 489
Dallas 447
San Jose 426
Nyköping 367
Chandler 334
Houston 311
Boardman 300
Wilmington 269
Seattle 265
Ann Arbor 254
Cambridge 230
Beijing 211
Jacksonville 180
Dearborn 164
Los Angeles 151
Helsinki 136
Santa Clara 124
The Dalles 116
New York 108
Council Bluffs 107
Ho Chi Minh City 106
Lauterbourg 91
Hong Kong 89
Boston 78
Shanghai 76
Nanjing 70
Hefei 69
Seoul 66
Hanoi 65
Dong Ket 60
Escalaplano 58
San Diego 53
Orem 48
Redwood City 48
Buffalo 47
Guangzhou 41
London 39
Chicago 36
Sassari 34
São Paulo 34
Milan 32
Hangzhou 31
Nanchang 30
Frankfurt am Main 29
Tianjin 27
Rome 26
Mountain View 25
Tokyo 25
Nuremberg 23
Redondo Beach 23
Shenyang 23
Toronto 23
Chennai 22
Atlanta 21
Phoenix 20
Brooklyn 19
Munich 19
Changsha 18
Montreal 18
Baghdad 17
Da Nang 16
Mumbai 16
Ottawa 16
Hebei 15
Jiaxing 14
Manchester 14
Norwalk 14
Pune 14
Rio de Janeiro 14
Tashkent 14
Brasília 13
Brussels 13
Dhaka 13
Shenzhen 13
Warsaw 13
Dublin 12
Jinan 12
Orange 12
Turku 12
Vienna 12
Zhengzhou 12
Mexico City 11
Nairobi 11
Washington 11
Stockholm 10
Belo Horizonte 9
Johannesburg 9
Amman 8
Falls Church 8
Jeddah 8
Moscow 8
New Delhi 8
Salt Lake City 8
San Francisco 8
Totale 160.436
Salva come PNG Salva come JPEG
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.748
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.846
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.626
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.549
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.532
Multi analytical technique study of human bones from an archaeological discovery 3.432
Multiple Sclerosis and environmental factors. 3.293
Adsorption of Cu2+ and Zn2+ on SBA-15 mesoporous silica functionalized with triethylenetetramine chelating agent 3.255
Gold - Old drug with new potentials 3.224
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.933
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.796
Metal coordination of thymosin β4: Chemistry and possible implications 2.786
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.751
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.655
Thymosin b4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study 2.615
Looking at new ligands for chelation therapy 2.560
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.482
null 2.477
Depleted uranium and human health 2.467
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.442
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.410
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.300
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.238
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.227
Do anti-diabetic drugs act as copper ligands? 2.210
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.203
Toxicity of nanoparticles: etiology and mechanisms 2.154
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.074
Tungsten or wolfram: Friend or foe? 2.053
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.038
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.974
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.965
Kill or cure: Misuse of chelation therapy for human diseases 1.923
The meaning of aluminium exposure on human health and aluminium-related diseases 1.911
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.894
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.893
Silver coordination compounds: A new horizon in medicine 1.869
Improving Metal Adsorption on Triethylenetetramine (TETA) Functionalized SBA-15 Mesoporous Silica Using Potentiometry, EPR and ssNMR 1.860
Alarming use of chelation therapy 1.849
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.835
Chemical features of in use and in progress chelators for iron overload 1.828
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.826
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.824
The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides 1.817
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.797
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.797
State of art in chelating agents for the clinical treatment of metal poisoning 1.791
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.780
Noble metals in medicine: Latest advances 1.779
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.776
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.765
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.760
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.734
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.710
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.624
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.611
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.578
Toxicity of nanoparticles 1.386
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know 1.281
Warns against unapproved ‘chelation therapy’ 1.200
null 1.188
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.151
Zinc as a drug for Wilson’s disease, non-alcoholic liver disease and covid-19-related liver injury 1.109
Grafting of the 2,8-dithia-5-aza-2,6-pyridinophane macrocycle on SBA-15 mesoporous silica for the removal of Cu2+ and Cd2+ ions from aqueous solutions: synthesis, adsorption, and complex stability studies 1.068
Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells 965
null 941
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 937
Nutritional iron deficiency: the role of oral iron supplementation 935
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis 922
Kojic Acid Derivatives as Iron (III) and Aluminium (III) Chelators 906
Kojic acid derivatives as double face ligands for metal and phosphate ions. 906
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 903
Metal complex formation and anticancer activity of cu(I) and cu(ii) complexes with metformin 863
Exploring cell surface markers and cell-cell interactions of human breast milk stem cells 855
Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexes 849
null 845
Manganese and cobalt binding in a multi-histidinic fragment 836
Metals and metal-nanoparticles in human pathologies: From exposure to therapy 811
Kojic Acid derivate as a selective inhibitor of mitosis in colorectal and glioblastoma cancer cells 807
Fluorescent squaramide ligands for cellular imaging and their encapsulation in cubosomes 737
Nickel Binding Sites in Histone Proteins: Spectroscopic and Structural Characterization 733
Potentiometric, spectrophotometric and computer studies with aspergillic acid and its derivatives 701
Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease 689
Interaction between aspergillic acid and iron(III). A potentiometric, UV-Vis, 1H-NMR and quantum chemical study 576
Cell starvation increases uptake of extracellular Thymosin β4 and its complexes with calcium 555
Toward the renal vesicle: Ultrastructural investigation of the cap mesenchyme splitting process in the developing kidney 549
Cooking Particulate Matter: A Systematic Review on Nanoparticle Exposure in the Indoor Cooking Environment 539
Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators 524
Human breast milk cells are positive for the pioneer transcription factor ISL1 521
NMR as a “gold standard” method in drug design and discovery 501
Nuovi derivati dell’acido kojico come chelanti per il ferro(III). 479
What doesn't kill you makes you stronger: Future applications of amyloid aggregates in biomedicine 465
A pilot study of occupational exposure to ultrafine particles during 3D printing in research laboratories 429
You are what you eat: Application of Metabolomics Approaches to Advance Nutrition Research 359
Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin 353
The interaction of aluminum with catecholamine-based neurotransmitters: Can the formation of these species be considered a potential risk factor for neurodegenerative diseases? 352
In silico design of mimosine containing peptides as new efficient chelators of aluminum 350
Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways 300
Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations 265
Therapeutic Properties of Vanadium Complexes 228
Totale 165.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.310 0 0 0 0 0 0 0 0 0 0 1.995 1.315
2021/20227.745 972 731 398 535 609 618 475 271 544 755 913 924
2022/202310.333 794 1.170 1.265 886 852 1.178 597 948 686 632 785 540
2023/202411.762 588 468 435 622 1.149 1.846 1.925 1.130 521 796 1.088 1.194
2024/202524.614 5.936 6.383 3.084 2.268 1.316 1.548 1.680 155 337 1.264 312 331
2025/20266.657 498 353 799 529 438 507 1.361 648 690 805 29 0
Totale 165.733